Since the beginning of the COVID-19 pandemic, I have heard stories of the difficulty in getting anything that opposed the “safe and effective” mantra of the COVID-19 modRNA vaccines past peer review and published. However, I didn’t think the system was that broken. As long as your study followed scientific rigour, there was no reason it wouldn’t be sent out for peer review and publication.
The initial attempts to publish our study on DNA in the COVID vaccines.
After tremendous work, including expanding the sample size to 32 COVID-19 modRNA vaccine vials from Ontario, Canada (10 Pfizer-BioNTech and 22 Moderna), our manuscript was polished and ready for the peer review process. I know that this work is scientifically solid. Even after one year, the only major criticism of the initial manuscript examining 27 vials on OSF Preprints was that we didn’t use RNase A during fluorometry to remove cross-talk from the modRNA. This was easily resolved and the work is ready for critique and publishing.